In this study, after 6 months of metformin therapy, conventional biomarkers of kidney function such as urinary albumin, urinary and serum Cr, as well as ACR and eGFR remained within the normal range in obese T2DM patients. This evidence concerns the gene ALB and type 2 diabetes mellitus.